Corrigendum to “Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo” (Biomedicine & Pharmacotherapy (2019) 116, (S0753332219317512), (10.1016/j.biopha.2019.109032))

The authors regret that there was an error in the article title in the originally published article. The title has now been corrected in this corrigendum. In addition, in material and methods 2.9 and 2.10, there are errors need to be corrected. On page 3, methods 2.9 extrinsic apoptosis should include caspase-8 (CaspGLOW™ Red Active Caspase-8 Staining Kit, BioVision) stain. However, on page 3, methods 2.10 the intrinsic apoptosis should remove caspase-8 (CaspGLOW™ Red Active Caspase-8 Staining Kit, BioVision) stain. The authors would like to apologise for any inconvenience caused.